The New York Times appealed to the European Court of Justice against the commission. The personal messages that President Ursula von der Leyen would have sent to the CEO of Pfizer will come before the jury’s lens Albert Bourla. And which until now have been kept secret by the European executive. To write is Politico.eu. The lawsuit was filed last year January 25th. But it was published today in the Register of the European Court. The EU Court of Justice website reports on the dispute between the NYT and the Commission. Without giving any further details on the case. However, sources close to the dossier have confirmed the information: The New York Times claims the commission is legally required to publish the news, which could contain information about agreements to purchase doses of the Covid-19 vaccine.
The SMS between von der Leyen and Bourla
The case of the defendant SMS Between from the Leyen and the CEO of Pfizer bourla he held court in the Euro Chamber for months. The Special Commission covid he asks the presidency of the European Parliament to hear the number one executive in the hemicycle. Commission spokesman yesterday morning Eric Mamer He explained that no request from President Roberta Metsola to hear von der Leyen has been received at this time. The NYT’s endorsement statement was quite sibylline: “We make many requests for access to documents of public interest. We can’t comment on the core issue of the case at this time.” The company broke the $100 billion revenue barrier in 2022. And it worked world first place in the ranking of pharmaceutical companies by sales and overtakes Johnson & Johnson, which was just ahead of him in 2021.
The study of vaccine prices
The first to ask about vaccine prices was Alexander Fanta from Netzpolitik.org, a German website specializing in digital rights. The request to be able to read the messages between von der Leyen and Bourla was not granted. The Commissioner for Transparency of the European Union Vera Jourova He replied that the messages could have been deleted due to their “fleeting nature”. The German newspaper Bild had made a similar request for access to documents. But the German newspaper wanted to link these to the negotiations that had led to the European Union’s purchase of vaccines made by Pfizer/BioNTech and AstraZeneca. The documents to which Bild had access did not include the email exchange between the President of the European Commission and the managing director of Pfizer.
Read more about Open
Also read:
